RAPH · Raphael Pharmaceutical Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“We do not believe that our current cash on hand will be sufficient to fund our projected operating requirements. This raises substantial doubt about our ability to continue as a going concern. At this time, there is no guarantee that we will be able to obtain an adequate level of financial resources required for the short and long-term support of our operations or that we will be able to obtain additional financing as needed, or meet the conditions of such financing, or that the costs of such financing may not be prohibitive. These conditions raise substantial doubt about our ability to continue as a going concern for a period within one year from the date of the financial statements included elsewhere in this Quarterly Report.”View the 10-Q filed Aug 14, 2026
Every disclosed holder of RAPH in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns RAPH
| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 0 | 0.00% |
| Insiders (Forms 3, 4, 5) | 6,087,521 | 30.17% |
| 13D/G-only blocks | 0 | 0.00% |
| Remaining | 14,088,897 | 69.83% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 20,176,418, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of RAPH
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
Pilo Shlomo
Insider
CIK 1903730 · Mar 2, 2025
Director, Chief Executive Officer, 10% Owner, issuer-wide
|
3,983,701 | ||
| 2 |
Louria Hayon Igal
Insider
CIK 1903781 · Nov 20, 2025
Director, Chief Technology Officer, issuer-wide
|
1,349,000 | ||
| 3 |
|
754,820 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.